Actively Recruiting
Registry to Assess the Safety and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with Failing/Absence of the Right Heart
Led by Berlin Heart GmbH · Updated on 2025-02-17
20
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to monitor the clinical safety and performance of the EXCOR Venous Cannula in context of an EXCOR VAD therapy to ensure continued acceptability of identified risks, to enable detecting emerging risks and to assess clinical improvement on both short- and long-term.
CONDITIONS
Official Title
Registry to Assess the Safety and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with Failing/Absence of the Right Heart
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient or their parent/guardian or legal representative has given written, signed, and dated informed consent
- Patient meets the indications for RVAD and BVAD use of the EXCOR VAD
- Patient is on the heart transplant list or eligible for heart transplantation
- Patient has a body surface area of 1.2 square meters or greater
You will not qualify if you...
- Patient or their parent/guardian or legal representative has not given consent
- Patient has contraindications to the use of the EXCOR VAD
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
LMU Klinikum
Munich, Germany
Actively Recruiting
Research Team
T
Thomas Schöndorf, Dr. Dr. PD
CONTACT
E
Eleonora Dal Sasso, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here